Suppr超能文献

长期抑酸治疗中幽门螺杆菌胃炎模式的变化

Changing patterns of Helicobacter pylori gastritis in long-standing acid suppression.

作者信息

Moayyedi P, Wason C, Peacock R, Walan A, Bardhan K, Axon A T, Dixon M F

机构信息

Centre for Digestive Diseases, General Infirmary at Leeds, Leeds, UK.

出版信息

Helicobacter. 2000 Dec;5(4):206-14. doi: 10.1046/j.1523-5378.2000.00032.x.

Abstract

BACKGROUND

Helicobacter pylori colonization and associated inflammation are influenced by local acid output. Infected subjects with acid-related diseases, such as gastroesophageal reflux disease (GERD) are likely to have an antral-predominant gastritis. We hypothesized that long-term acid suppression would result in relatively greater bacterial colonization in the corpus leading to diffuse or corpus-predominant gastritis and that this would be prevented by prior H. pylori eradication.

MATERIALS AND METHODS

To investigate this, we conducted a prospective, double-blind trial of the effect on gastric histology of 12-month maintenance treatment with omeprazole in H. pylori-positive GERD patients randomly assigned to either an eradication or omeprazole-alone regime. A control group of 20 H. pylori-negative GERD patients also received omeprazole throughout the study period. Biopsies taken at baseline and at 12 months were graded "blind" by a single observer according to the updated Sydney System. The 41 H. pylori-positive subjects with grade B or C esophagitis were randomly assigned (20 to omeprazole alone, 21 to eradication) and 33 subjects completed the 12-month study.

RESULTS

There was a significant decline in antral chronic inflammation in initially positive patients between baseline and end in both the eradication group (p =.035) and the omeprazole-alone group (p =.008). However, corpus chronic inflammation increased in the omeprazole-alone group (p =.0156) but decreased in the eradication group. The change toward corpus predominance between baseline and end for the omeprazole-alone group is highly significant (p =.0078). Furthermore, 5 of 11 in the omeprazole-alone group developed mild corpus atrophy, compared to 0 of 8 who had undergone H. pylori eradication. The change in frequency of corpus atrophy between the two groups is significant (p =.02).

CONCLUSION

In H. pylori-positive subjects with GERD, long-term acid suppression leads to a shift from antral- to corpus-predominant gastritis that can be prevented by prior eradication. The shift is accompanied by an increase in corpus atrophy. H. pylori infection should be eradicated prior to long-term acid suppression with proton pump inhibitors.

摘要

背景

幽门螺杆菌定植及相关炎症受局部酸分泌的影响。患有酸相关疾病(如胃食管反流病,GERD)的感染患者可能以胃窦为主的胃炎。我们假设长期抑酸会导致胃体部细菌定植相对增加,从而导致弥漫性或胃体为主的胃炎,而这可通过预先根除幽门螺杆菌来预防。

材料与方法

为研究此问题,我们对幽门螺杆菌阳性的GERD患者进行了一项前瞻性、双盲试验,比较了随机分配至根除组或仅使用奥美拉唑组的患者接受12个月奥美拉唑维持治疗对胃组织学的影响。20名幽门螺杆菌阴性的GERD患者组成的对照组在整个研究期间也接受奥美拉唑治疗。由一名观察者根据更新后的悉尼系统对基线和12个月时采集的活检标本进行“盲法”分级。41名患有B级或C级食管炎的幽门螺杆菌阳性受试者被随机分配(20名仅接受奥美拉唑治疗,21名接受根除治疗),33名受试者完成了12个月的研究。

结果

在根除组(p = 0.035)和仅使用奥美拉唑组(p = 0.008)中,初始阳性患者从基线到研究结束时胃窦慢性炎症均显著下降。然而,仅使用奥美拉唑组胃体慢性炎症增加(p = 0.0156),而根除组则下降。仅使用奥美拉唑组从基线到研究结束时向胃体为主的转变非常显著(p = 0.0078)。此外,仅使用奥美拉唑组的11名患者中有5名出现轻度胃体萎缩,而接受幽门螺杆菌根除治疗的8名患者中无人出现。两组之间胃体萎缩频率的变化具有显著性(p = 0.02)。

结论

在幽门螺杆菌阳性的GERD患者中,长期抑酸会导致从胃窦为主的胃炎转变为胃体为主的胃炎,预先根除幽门螺杆菌可预防这种转变。这种转变伴随着胃体萎缩的增加。在使用质子泵抑制剂进行长期抑酸之前,应根除幽门螺杆菌感染。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验